SUVEN LIFE SCIENCES LTD Financial Ratios
SUVEN · Healthcare · Current price ₹305.5
P/E ratio
-29.0x
P/B ratio
14.9x
ROE
-46.7%
ROCE
-45.4%
Debt / Equity
0.03
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | -29.0x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 14.9x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | -46.7% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | -45.4% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.03 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with SUVEN LIFE SCIENCES LTD's latest numbers.
SUVEN LIFE SCIENCES LTD profitability
SUVEN LIFE SCIENCES LTD generates a return on equity of -46.7% and a return on capital employed of -45.4%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.03 and a P/E of -29.0x, SUVEN LIFE SCIENCES LTD is conservatively financed. Our overall business-quality score for the company is 3.3 / 10.
Understand the ratios
More on SUVEN LIFE SCIENCES LTD
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.